Invention Grant
- Patent Title: Combination therapy for treating cancer
-
Application No.: US15809445Application Date: 2017-11-10
-
Publication No.: US10463671B2Publication Date: 2019-11-05
- Inventor: Heike Keilhack , Sarah K. Knutson , Kevin W. Kuntz
- Applicant: Epizyme, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Epizyme, Inc.
- Current Assignee: Epizyme, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Cooley LLP
- Agent Heidi A. Erlacher; Christine C. Pemberton
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07K16/28 ; A61K31/573 ; A61K45/06 ; A61K39/395 ; A61K31/69 ; A61K31/675 ; A61K31/635 ; A61K31/404 ; A61K31/52 ; A61K31/519 ; A61K31/4965 ; A61K31/496 ; A61K31/4375 ; A61K31/436 ; A61K39/00
Abstract:
The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer agents such as prednisone, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
Public/Granted literature
- US20180280402A1 COMBINATION THERAPY FOR TREATING CANCER Public/Granted day:2018-10-04
Information query
IPC分类:
